Online Survey in Studying Smoking Attitudes and Behaviors Among Current Smokers
NCT ID: NCT03863795
Last Updated: 2021-09-08
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1100 participants
OBSERVATIONAL
2019-02-04
2019-03-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors
NCT02233842
Young Adults' Responses to Anti-smoking Messages
NCT01954407
Enhanced E-cigarette Coaching Intervention for Dual Users of Cigarettes and E-cigarettes
NCT03575468
Tobacco Treatment in the Context of Lung Cancer Screening
NCT03927989
Message Testing in Older Adult Smokers
NCT05471349
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To examine if self-affirmation attenuates the effects of cigarette smoking stigmatization on smoking risk perceptions, pro-smoking beliefs, and intentions to change smoking behavior.
OUTLINE:
Participants are recruited and pre-screened via an online crowdsourcing program called Amazon Mechanical Turk (MTurk). Participants then respond to a one-time research survey over 20 minutes on SurveyGizmo, an on-line survey software platform.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Observational (survey)
Participants are recruited and pre-screened via an online crowdsourcing program MTurk, and then respond to a one-time research survey over 20 minutes on SurveyGizmo, an on-line survey software platform
Survey Administration
Respond to SurveyGizmo survey online
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey Administration
Respond to SurveyGizmo survey online
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Annette Kaufman
Role: PRINCIPAL_INVESTIGATOR
NCI Division of Cancer Control and Population Sciences
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NCI Division of Cancer Control and Population Sciences
Rockville, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Sorgen LJ, Ferrer RA, Klein WMP, Kaufman AR. Smoking self-concept moderates the effects of self-affirmation on smoking-related beliefs and behavioral intentions. Psychol Health. 2022 Aug;37(8):964-984. doi: 10.1080/08870446.2021.1912346. Epub 2021 Apr 19.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2019-01325
Identifier Type: REGISTRY
Identifier Source: secondary_id
19-NCI-00810
Identifier Type: OTHER
Identifier Source: secondary_id
NCI-2019-01325
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.